Can there possibly be a great walk on Britain’s worst-selling Ordnance Survey Explorer map? That’s a question we were only ...

The closure will start from February 6 and will last for up to six months – plus, there’s no alternative route. According to ...

OS Animal Health (OSAH), a wholly owned OS Therapies (OSTX) subsidiary, targets an IPO on NYSE American or Nasdaq ...

Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...

Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Corcept recently suffered a blow after relacorilant was rejected by the FDA for use in Cushing’s syndrome.

MemRL separates stable reasoning from dynamic memory, giving AI agents continual learning abilities without model fine-tuning ...

After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...

K price tag, one must wonder why the Signature finds itself in the sub-60K segment, despite the same chip. So without any ...

Carvykti sales surge, MRD FDA guidance speeds label expansion, and strong cash runway. Click for more on LEGN stock.

The FDA believes that data on MRD and complete response can expedite new drug delivery compared with long-term survival ...